Remove Competition Remove Medicine Remove Pharmacology Remove Prescription
article thumbnail

How NLP Helps Life Sciences Companies Unlock Insights from Drug Labels

PM360

When developing content for new drug labels, life sciences companies’ regulatory teams face challenges in gathering intelligence to better understand competitive factors, market dynamics, and effective approval strategies. Food and Drug Administration (FDA) or European Medicines Agency (EMA). Challenges in Working with Label Data.

article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

Regardless of the reasons, investors, pharma, and research organizations are recognizing that advanced digital health tools will be a significant competitive advantage and generate meaningful return on investment (ROI) in an industry that is becoming more personalized and specialized.

Pharma 110
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmaceutical Sales Training: Mastering the Art of Modern Pharma Sales

Contrarian Sales Techniques

Regulation changes, like the introduction of the Prescription Drug Marketing Act in the 1980s, brought about a more structured approach. Another game-changer has been the shift towards personalized medicine. It enhances your skill set, making you more valuable to your organization and more competitive in the job market.

article thumbnail

The Buyers Guide to Supercharging your Pharma Field Force Sales Performance 

Quantified

On the one hand, patient need for access and business need to restore and accelerate sales and prescription momentum have never been more critical. Having a flawless technical grasp of the medicine is no longer sufficient. On the other hand, HCP access for the field force has never been more challenging.

Sales 52